CDNA
CareDx, Inc.Company Information
- Company Name
- CareDx, Inc.
- CIK
- CIK0001217234
- Category
- Large accelerated filer
- Ticker: Exchange
- CDNA: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8071
- SIC Description
- Services-Medical Laboratories
- Ticker
- CDNA
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-08-05
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 392,686
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 52,746,551
- Shares outstanding
- 51,469,375
- Ownership
- 102.48%
Earnings Market Reaction
- Filing date
- 2026-07-30
- Price on filing date
- —
- 1-month reaction
- 27.59%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 374 | 78 | 65 | 91 | 68 | 89 | 115 | 95 | 96 | 93 | 82 | 76 | ||||||
| Marketable Securities Current | 0 | 109 | 112 | 103 | 118 | 142 | 146 | 145 | 133 | 123 | 153 | 192 | ||||||
| Accounts Receivable Net Current | 34 | 45 | 43 | 48 | 67 | 71 | 65 | 67 | 66 | 60 | 51 | 52 | ||||||
| Inventory Net | 7 | 26 | 27 | 28 | 28 | 23 | 20 | 19 | 19 | 20 | 19 | 18 | ||||||
| Prepaid Expense And Other Assets Current | 14 | 11 | 11 | 30 | 26 | 25 | 7 | 7 | 6 | 7 | 8 | 7 | ||||||
| Assets Current | 429 | 269 | 257 | 300 | 307 | 350 | 352 | 334 | 321 | 303 | 314 | 345 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 27 | 33 | 33 | 31 | 32 | 33 | 34 | 34 | 34 | 34 | 35 | 35 | ||||||
| Operating Lease Right Of Use Asset | 16 | 21 | 23 | 24 | 25 | 26 | 24 | 26 | 27 | 29 | 30 | 31 | ||||||
| Marketable Securities Noncurrent | 0 | 11 | 24 | - | - | - | 0 | - | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 19 | 32 | 32 | 33 | 36 | 37 | 38 | 40 | 42 | 43 | 46 | 46 | ||||||
| Goodwill | 36 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | ||||||
| Restricted Cash And Cash Equivalents Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Assets Noncurrent | 6 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | ||||||
| Assets | 533 | 411 | 413 | 432 | 444 | 490 | 491 | 477 | 467 | 452 | 467 | 501 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 9 | 9 | 10 | 12 | 10 | 8 | 8 | 6 | 6 | 10 | 13 | 9 | ||||||
| Employee Related Liabilities Current | 35 | 21 | 38 | 23 | 19 | 14 | 38 | 30 | 25 | 15 | 20 | 17 | ||||||
| Litigation Reserve Current | - | - | - | 20 | 20 | 20 | - | - | - | - | - | - | ||||||
| Accrued Liabilities And Other Liabilities | 50 | 50 | 42 | 44 | 44 | 43 | 43 | 45 | 47 | 46 | 45 | 47 | ||||||
| Liabilities Current | 94 | 79 | 90 | 99 | 93 | 85 | 89 | 81 | 78 | 70 | 78 | 73 | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 2 | - | ||||||
| Warrants And Rights Outstanding | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 13 | 18 | 20 | 21 | 23 | 24 | 22 | 24 | 25 | 27 | 28 | 29 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 97 | 97 | 98 | 97 | 0 | ||||||
| Liabilities | 107 | 98 | 110 | 121 | 117 | 110 | 113 | 204 | 202 | 196 | 205 | 107 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 931 | 1,052 | 1,044 | 1,036 | 1,029 | 1,023 | 1,013 | 985 | 969 | 960 | 947 | 937 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | -6 | -6 | -6 | -6 | -7 | -9 | -7 | -8 | -8 | -7 | -9 | ||||||
| Retained Earnings Accumulated Deficit | -505 | -733 | -735 | -719 | -695 | -637 | -626 | -704 | -697 | -695 | -678 | -534 | ||||||
| Stockholders Equity | 426 | 314 | 303 | 311 | 327 | 379 | 378 | 273 | 265 | 256 | 261 | 394 | ||||||
| Liabilities And Stockholders Equity | 533 | 411 | 413 | 432 | 444 | 490 | 491 | 477 | 467 | 452 | 467 | 501 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 51 | 51 | 51 | 51 | 53 | 55 | 55 | 53 | 53 | 52 | 52 | 54 | ||||||
| Shares Outstanding | 51 | 51 | 51 | 51 | 53 | 55 | 55 | 53 | 53 | 52 | 52 | 54 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCareDx, Inc. (CDNA) — SEC Financial Statements & Analysis
CareDx, Inc. (CDNA) is a services-medical laboratories company, incorporated in DE. CareDx, Inc. trades on Nasdaq as: CDNA. CareDx, Inc. (CDNA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30. Based on that filing, CareDx, Inc. carries a market cap of $1.47B, a P/E ratio of 13.21x, a P/B ratio of 3.45x, a P/S ratio of 3.20x, an enterprise value of $1.09B, and an EV/EBITDA multiple of 8.92x. On profitability, it posts a gross margin of 85.91%, an operating margin of 23.61%, a net margin of 24.23%, a Return on Equity (ROE) of 29.49%, a Return on Assets (ROA) of 22.72%, and a Return on Invested Capital (ROIC) of 64.27%. Per share, it reports EPS of $2.16, diluted EPS of $2.08, free cash flow per share of $1.70, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 34.41% year-over-year, net income growth of 90.94% year-over-year, and EPS growth of 101.46% year-over-year. On the balance sheet, it maintains a current ratio of 4.58x, a quick ratio of 4.35x, working capital of $335.52M, a debt-to-equity ratio of 0.25x, a debt ratio of 0.2, an interest coverage ratio of 14.10x, free cash flow of $87.31M (TTM), and net debt of $-374.16M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.47B
- P/E TTM
- 13.21x
- EPS TTM
- $2.16
- P/B TTM
- 3.45x
- ROE TTM
- 29.49%
- ROA TTM
- 22.72%
- Debt To Equity
- 0.25x
- Free Cash Flow TTM
- $87.31M
- Net Revenue TTM Growth 1Y
- 34.41%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CareDx, Inc. in?
CareDx, Inc. (CDNA) operates in the Services-Medical Laboratories industry.
What exchange does CDNA trade on?
CareDx, Inc. (CDNA) trades on the Nasdaq.
Where is CareDx, Inc. incorporated?
CareDx, Inc. is incorporated in DE.
When was CareDx, Inc. (CDNA)'s most recent SEC filing?
CareDx, Inc. (CDNA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30.
What is CDNA's market cap?
CareDx, Inc. (CDNA) has a market capitalization of $1.47B as of 2026-06-30.
What is CDNA's P/E ratio?
CareDx, Inc. (CDNA)'s trailing twelve month P/E ratio is 13.21x as of 2026-06-30.
What is CDNA's EPS (earnings per share)?
CareDx, Inc. (CDNA)'s trailing twelve month EPS is $2.16 as of 2026-06-30.
What is CDNA's ROE (return on equity)?
CareDx, Inc. (CDNA)'s trailing twelve month Return on Equity (ROE) is 29.49% as of 2026-06-30.
What is CDNA's ROA (return on assets)?
CareDx, Inc. (CDNA)'s trailing twelve month Return on Assets (ROA) is 22.72% as of 2026-06-30.
What is CDNA's ROIC (return on invested capital)?
CareDx, Inc. (CDNA)'s trailing twelve month Return on Invested Capital (ROIC) is 64.27% as of 2026-06-30.
What is CDNA's EV/EBITDA?
CareDx, Inc. (CDNA)'s trailing twelve month EV/EBITDA is 8.92x as of 2026-06-30.